Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial

por Pagan, Fernando. L., Hebron, Michaeline L., Wilmarth, Barbara, Torres-Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Anjum, Muhammad, Arellano, Joy, Howard, Helen H., Shi, Wangke, Mulki, Sanjana, Kurd-Misto, Tarick, Matar, Sara, Liu, Xiaoguang, Ahn, Jaeil, Moussa, Charbel
Publicado 2020

Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease

por Turner, Raymond S., Hebron, Michaeline L., Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, J. Nathan, Anjum, Muhammad, Pagan, Fernando, Torres‐Yaghi, Yasar, Shi, Wangke, Mulki, Sanjana, Ferrante, Dalila, Matar, Sara, Liu, Xiaoguang, Esposito, Giuseppe, Berkowitz, Frank, Jiang, Xiong, Ahn, Jaeil, Moussa, Charbel
Publicado 2020

BACH2 Enforces the Transcriptional and Epigenetic Programs of Stem-Like CD8(+) T cells

por Yao, Chen, Lou, Guohua, Sun, Hong-Wei, Zhu, Ziang, Sun, Yi, Chen, Zeyu, Chauss, Daniel, Moseman, E. Ashley, Cheng, Jun, D’Antonio, Marc A., Shi, Wangke, Shi, Junwei, Kometani, Kohei, Kurosaki, Tomohiro, Wherry, E. John, Afzali, Behdad, Gattinoni, Luca, Zhu, Yuwen, McGavern, Dorian B., O’Shea, John J., Schwartzberg, Pamela L., Wu, Tuoqi
Publicado 2021